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HEPATITIS B VACCINATION COVERAGE AND POSTVACCINATION SEROLOGIC TESTING AMONG 
MEDICAL STUDENTS AT A PUBLIC UNIVERSITY IN BRAZIL 
Eduardo Pernambuco de SOUZA(1) & Marcelo de Souza TEIXEIRA(2)
SUMMARY
The aim of this cross-sectional study was to determine the hepatitis B vaccination coverage among medical students at a public 
university in Rio de Janeiro, Brazil, and their compliance with the postvaccination serologic testing recommendations. Of the total of 
858 students, 675 (78.7%) participated in the study. Among the participants, 48.9% (95% CI: 45.1% to 52.7%) were vaccinated against 
hepatitis B (received ≥ 3 doses of the vaccine), 31.6% were not (received 0, 1 or 2 doses), and 19.6% did not know their vaccination 
status. Hepatitis B vaccination coverage increased from 26.0% among first-year students to 70.6% among sixth-year students while 
the prevalence of unknown vaccination status decreased from 39.7% among first-year students to 2.4% among sixth-year students. The 
frequency of unvaccinated students ranged from 23.7% among fifth-year students to 34.4% among first-year students. Only 34.8% of 
the vaccinated students performed the anti-HBs testing after vaccination. Among these medical students, we found a low adherence 
to the hepatitis B vaccination and to the postvaccination serologic testing. A comprehensive hepatitis B immunization program should 
be offered to students at this medical school.
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INTRODUCTION
The hepatitis B virus infection can cause severe chronic liver 
disease, and is a public health problem in several countries31. In Brazil, 
approximately 14,000 cases of hepatitis B virus infection are reported 
every year and 120,343 cases were reported from 1999 to 20113.
The hepatitis B virus can be transmitted through percutaneous or 
mucosal exposure to infected blood or body fluids, and health-care 
personnel are at risk of acquiring the disease from needle stick injuries or 
other types of occupational exposures9. This risk may be higher during the 
professional training period11,14,24,25. Therefore, the hepatitis B vaccination 
is strongly recommended for health-care personnel, including medical 
students and students of other health professions, and these individuals 
should perform the hepatitis B surface antibody (anti-HBs) testing 1-2 
months after vaccination to evaluate the protective antibody response 
to the vaccine4,11. 
In Brazil, students currently entering medical school were born before 
the implementation of universal hepatitis B vaccination of infants in 
19985. Vaccination of adolescents was recommended in 20015, but this 
group is difficult to be reached by immunization programs, and studies 
have reported low vaccination coverage among Brazilian adolescents6,27. 
Consequently, students may enter medical school still unvaccinated 
against hepatitis B, and immunization programs at medical schools 
could contribute to vaccination of susceptible students. However, not all 
Brazilian medical schools have implemented such programs or student 
vaccination requirements. Therefore, it cannot be assumed a priori that 
most medical students are properly protected against hepatitis B. In fact, 
inadequate hepatitis B vaccination coverage has been observed among 
medical students and students of other health professions in Brazil7,8,12,29. 
Information on vaccination coverage among medical students 
regarding the vaccines that are recommended for health-care personnel 
can contribute to the implementation of appropriate immunization efforts 
at medical schools. In this context, the aim of this study was to determine 
the hepatitis B vaccination coverage among medical students at a public 
university in Brazil, and their compliance with the postvaccination 
serologic testing recommendations.
MATERIALS AND METHODS
This cross-sectional study was conducted at the Universidade 
Federal do Estado do Rio de Janeiro Medical School. This medical 
school is one of the three public medical schools located in the city 
of Rio de Janeiro, Brazil, and offers a six-year course in medicine. 
Approximately one hundred and forty students are admitted each 
year. Students begin to have contact with patients and to perform 
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some procedures, with risk of occupational exposures, in the second 
year of medical school. All medical students enrolled at this school in 
the second semester of 2010 were eligible to participate in this study. 
The invitation to participate was made during mandatory classes for 
students on different occasions.
A self-administered questionnaire was used to collect the following 
data: age, sex, and the student’s current year in medical school; whether 
the student had been vaccinated against hepatitis B or not; the number of 
vaccine doses received by the student; whether the student had performed 
the anti-HBs testing after vaccination, and the approximate interval 
between the last vaccine dose and the anti-HBs testing.
In the present study, students were considered “vaccinated” against 
hepatitis B when they had received three or more doses of the vaccine, 
and were considered “unvaccinated” when they had not received the 
vaccine or had received only one or two vaccine doses. Vaccination status 
was considered “unknown” when students reported that they did not 
know if they had received the vaccine or they did not know the number 
of doses received.
The data were entered into an electronic database using double data 
entry, and a descriptive analysis was performed for all study variables. The 
95% confidence interval was calculated for the frequency of students who 
were “vaccinated” against hepatitis B. Vaccination status was compared 
across gender using the chi-square test. Analyses were performed with 
Epi Info (version 3.5.3 - 2011).
This study was approved by the ethics review committee of the 
Gaffrée e Guinle University Hospital at the Universidade Federal do 
Estado do Rio de Janeiro, and all students signed an informed consent 
before entering the study.
RESULTS
In the second half of 2010, 858 students were enrolled at the 
Universidade Federal do Estado do Rio de Janeiro Medical School, 
and 675 (78.7%) responded to the survey questionnaire. Response rate 
ranged from 63.0% among sixth-year students to 92.4% among fourth-
year students (Table 1). The mean age of the students was 22.8 years 
± 2.8 (range: 17 to 49 years): 59.7% were female students, and 40.3% 
were male students. Information on age was missing for eight students.
Of the total of 675 students, 330 students (48.9%; 95% CI: 45.1% 
to 52.7%) were vaccinated against hepatitis B (received ≥ 3 doses of the 
vaccine), 213 (31.6%) were unvaccinated (received zero, one or two doses 
of the vaccine), and 132 students (19.6%) did not know their vaccination 
status (did not know if they had received the vaccine or did not know the 
number of vaccine doses received). Among the 213 students who were 
considered unvaccinated against hepatitis B, 80 students (37.6%) did not 
receive any dose of the vaccine, 51 students (23.9%) received one dose, 
and 82 students (38.5%) received two doses.
The ≥ 3-dose hepatitis B vaccination coverage increased from 26.0% 
among first-year students to 70.6% among sixth-year students. On the 
other hand, the prevalence of unknown vaccination status decreased from 
39.7% among first-year students to 2.4% among sixth-year students. The 
frequency of unvaccinated students ranged from 23.7% among fifth-year 
students to 34.4% among first-year students (Table 1).
Among male students (n = 272), 47.8% were vaccinated against 
hepatitis B, 32.4% were not, and 19.9% did not know their vaccination 
status. Among female students (n = 403), 49.6% were vaccinated, 31.0% 
were not, and 19.4% did not know their vaccination status (p = 0.89).
Of the total of 330 fully vaccinated students, 115 students (34.8%) 
performed the anti-HBs testing after vaccination. Additionally, 15 
students who had received one or two doses of the vaccine, and eight 
students who did not know the number of doses of the vaccine they 
had received also performed the anti-HBs testing after vaccination. 
Accordingly, a total of 138 students did the postvaccination serologic 
testing. Most students performed the anti-HBs testing one or more years 
after vaccination or did not know this interval (Table 2).
DISCUSSION
In this study we observed a low uptake of the hepatitis B vaccine 
among a group of Brazilian medical students since 31.6% of them were 
not fully vaccinated. The proportion of unvaccinated students may have 
even been underestimated because approximately 20% of the students 
Table 1
Response rate and hepatitis B vaccination status according to year of medical school among Brazilian medical students
Year of medical 
school
Response rate (n = 858) Vaccination status (n = 675)
Vaccinated Unknown Unvaccinated
n/N % n % n % n %
First 131/149 87.9 34 26.0 52 39.7 45 34.4
Second 102/145 70.3 31 30.4 36 35.3 35 34.3
Third 114/147 77.6 58 50.9 19 16.7 37 32.5
Fourth 146/158 92.4 81 55.5 15 10.3 50 34.2
Fifth 97/124 78.2 66 68.0 8 8.2 23 23.7
Sixth 85/135 63.0 60 70.6 2 2.4 23 27.1
Total 675/858 78.7 330 48.9 132 19.6 213 31.6
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did not know their vaccination status, and some of these students could 
be unvaccinated. In addition and perhaps more importantly, among 
students attending the final year of medical school, hepatitis B vaccination 
coverage was only 70.6%, and in this group 2.4% of the students did not 
know their vaccination status.
Few studies have investigated the hepatitis B vaccination coverage 
among medical students in Brazil1,7,12,24. One study reported a vaccination 
coverage of 71.3% among fifth-year medical students12 and this result 
was similar to that observed among our students who were in the same 
year of medical school (68.0%). In another study, a higher vaccination 
coverage and of 86.8% was observed among second- to sixth-year 
medical students24. At a medical school in the state of Santa Catarina, 
Brazil only 53.8% of the students were vaccinated against hepatitis B, 
but in this study the number of vaccine doses was not determined, and the 
vaccination status was unknown for approximately 43% of the students1. 
Other studies conducted in Brazil assessed the hepatitis B vaccination 
coverage among different groups of health-care personnel, with varying 
results. As among our students, vaccine uptake was suboptimal in some 
of these groups2,8,17,28-30. Vaccination coverage of less than 80% has 
been reported among physicians in two Brazilian cities17,28, residents in 
pediatrics30, dental students8,29, and health-care workers in the city of Belo 
Horizonte2. Among health-care students, including medical students, who 
were exposed to biological material in São Paulo-Brazil, only 77.1% of 
them had received three or more doses of the vaccine18. On the other hand, 
vaccination coverage of more than 90% was observed among dentists16 
and physicians2,15 in some Brazilian cities. However, one must be careful 
to compare the results of these studies because different methods were 
used to assess the vaccination status (self-reported vaccination status or 
vaccination records), and in some studies it is unclear whether vaccinated 
individuals were only those who had received the 3-dose vaccine series 
or were individuals who had received at least one dose of the vaccine. 
In other countries, including the US, optimal hepatitis B vaccination 
coverage among health-care personnel has not been achieved either22. 
Interestingly, we observed that hepatitis B vaccination coverage 
increased progressively from 26.0% among first-year students to 70.6% 
among sixth-year students while the prevalence of unknown vaccination 
status decreased from 39.7% to 2.4%. Since this study was not prospective 
and we did not investigate when students were vaccinated, whether before 
or during the medical course, we cannot explain these findings with 
certainty. Perhaps, students attending different years of the medical course 
had already different vaccination status when they were admitted to 
medical school. However, during the medical course students have several 
opportunities to learn about the importance of being vaccinated against 
hepatitis B and of knowing their vaccination status. The acquisition of 
this knowledge might have contributed to a higher vaccination coverage 
and a lower prevalence of unknown vaccination status among students 
attending the last years of the medical course. Nevertheless, in each year 
of this medical course, approximately a quarter to a third of the students 
had not received the 3-dose hepatitis B vaccine series.
In Brazil, the hepatitis B vaccine is available free of charge to health-
care personal, including medical students, at a large network of health-
care facilities. In the present study, we did not investigate the reasons that 
could eventually explain why students were not vaccinated. However, the 
medical school where this study was conducted does not have a student 
immunization program or vaccination requirements, and this might have 
contributed to the low hepatitis B vaccine uptake among our study group. 
In this regard, a higher hepatitis B vaccination coverage was reported 
among Brazilian medical students to whom an immunization program 
was offered at their medical school24. 
Exposure to blood or body fluids potentially contaminated with 
hepatitis B virus is common among medical students12,14,18,24-26. Moreover, 
in Brazil, the number of confirmed cases of hepatitis B infection is 
higher among young adults than among other age groups, and most 
cases of the disease are probably acquired through sexual contact3. The 
majority of medical students are young adults, and thus unvaccinated 
medical students may be at risk of acquiring the disease not only through 
occupational exposures but also by sexual contact.
In the present study, only 34.8% of the vaccinated students performed 
the anti-HBs testing after vaccination to determine their antibody response 
to the vaccine. However, based on this result we cannot conclude 
whether or not the students complied with the postvaccination serologic 
testing recommendations for health-care personnel because we did not 
investigate when students were vaccinated, and the anti-HBs testing was 
not mandatory for those students vaccinated in the past, before entering 
medical school11. In fact, different recommendations would have been 
acceptable for students vaccinated before entering medical school: not 
to perform the anti-HBs testing unless they were exposed to blood or 
body fluids11 or to perform the testing and eventually administer a booster 
dose of the vaccine to those with anti-HBs concentrations of less than 10 
mIU/mL4,10. On the other hand, students vaccinated during the medical 
course should have performed the anti-HBs testing 1-2 months after 
the last dose of the hepatitis B vaccine series4,11. Nevertheless, we can 
conclude that the response to the vaccine was unknown for most of the 
vaccinated students, and this can be an issue in some circumstances. When 
the response to the vaccine is unknown, the management of health-care 
personnel potentially exposed to hepatitis B virus is more complex, and 
in this context the anti-HBs testing should be performed immediately. 
However, in some settings in Brazil, the anti-HBs testing or its results 
may not be readily available. Other studies conducted in Brazil also 
reported that a significant proportion (approximately 32% to 48%) of 
health-care personnel who were vaccinated against hepatitis B did not 
perform the postvaccination serologic testing15,24,28. 
In addition, most students performed the anti-HBs testing one or 
more years after the last dose of the vaccine or did not know how long 
Table 2
Approximate interval between the last dose of the hepatitis B vaccine and the 
anti-HBs testing among Brazilian medical students (n = 138)
Approximate interval between the last dose of the 
vaccine and the anti-HBs testing
Students
n %
< 1 year 23 16.7
1-4 years 34 24.6
≥ 5 years 19 13.8
Unknown 58 42.0
Missing 4 2.9
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after vaccination the testing had been performed. The anti-HBs testing 
performed years after vaccination is not adequate for evaluating the 
response to the vaccine because anti-HBs concentrations decline over 
time. However, individuals who responded to the 3-dose vaccine series 
remain protected even if their anti-HBs concentration declines to below 
10 mIU/mL due to immune memory23. In this respect, among health-
care students in Taiwan, who were vaccinated during infancy with a 
recombinant hepatitis B vaccine, a study reported that after 16 years only 
33% had protective levels of anti-HBs, but 95.9% of the anti-HBs negative 
students achieved protective levels of anti-HBs after a booster dose of 
the vaccine, indicating the presence of immune memory20. Perhaps, in 
the present study, students performed the anti-HBs testing years after 
vaccination because they were vaccinated in the past and desire to know 
whether they were protected against hepatitis B or not. In this context, 
to perform the anti-HBs testing is an acceptable option as far as the test 
results are correctly interpreted and the students are properly counseled.
In Brazil, universal hepatitis B vaccination of infants was 
implemented in 1998, and vaccination of adolescents younger than 20 
years of age was recommended in 20015. A study conducted among 
Brazilian medical students in 2009 reported that approximately 60% of 
the students were vaccinated against hepatitis B before entering medical 
school24. In the future, more students will possibly enter medical school 
already vaccinated against hepatitis B and medical schools will have to 
decide whether to recommend the anti-HBs testing for all students or 
only for those who have an occupational exposure.
This study has some limitations. Assessment of vaccine uptake was 
based on student self-reported vaccination status, and misclassifications 
might have occurred. However, the use of vaccination records to assess 
vaccination status can also lead to misclassification of individuals with 
missing vaccination records. Among some groups, missing or unavailable 
vaccination records are not uncommon15,30, and a study conducted among 
Brazilian nursing and medical students reported that, after several 
attempts, only 11% of the students provided their vaccination cards7. 
Furthermore, we could have had more accurate and complete information 
on the postvaccination serologic testing if we had determined when 
students were vaccinated, whether at medical school or before, and if we 
had reviewed the laboratory reports for the anti-HBs testing. However, 
laboratory reports are not easily available. Some fifth- and sixth-year 
students answered the study questionnaire later than the other students. 
Consequently, they had more time to clarify their vaccination status, and 
to complete their hepatitis B vaccination schedule, perhaps influenced by 
their knowledge about the survey. This might have contributed to increase 
the vaccination coverage in this group. On the other hand, there are few 
studies reporting on hepatitis B vaccination coverage among Brazilian 
medical students, and the present study, despite its limitations, can provide 
additional information regarding health-care students compliance with 
the recommended vaccines in Brazil.
In conclusion, in the present study we found a low uptake of the 
hepatitis B vaccine among a group of Brazilian medical students, 
despite the wide availability of the vaccine. In addition, most vaccinated 
students did not perform the postvaccination serologic testing and thus, 
their response to the vaccine was unknown. It is well recognized that 
medical students have a high risk of being exposed to blood and body 
fluids potentially contaminated with hepatitis B virus, and hepatitis B 
vaccination is mandatory or recommended for these students in several 
countries11,13,19,21 . Accordingly, this medical school should urgently 
consider to implement a comprehensive student immunization program 
against hepatitis B, which may contribute to improve students’ adherence 
to vaccination. This program should be offered early in the medical 
course and provide not only vaccination but also screening and follow up. 
Furthermore, education on prevention and management of occupational 
exposures should be also provided to these students, and counseling 
should be immediately available in case of exposure. Finally, continuous 
surveillance of hepatitis B vaccination coverage among medical students 
should be undertaken in Brazil, especially at those medical schools which 
do not have student vaccination requirements.
RESUMO
Cobertura vacinal para a hepatite B e teste sorológico pós-vacinal 
entre estudantes de medicina de universidade pública no Brasil
O objetivo deste estudo transversal foi determinar a cobertura vacinal 
para a hepatite B entre estudantes de medicina de uma universidade 
pública no Rio de Janeiro, Brasil e a sua adesão às recomendações 
sobre o teste sorológico pós-vacinal. De um total de 858 estudantes, 675 
(78,7%) participaram do estudo. Entre os participantes, 48,9% (IC de 
95%: 45,1% a 52,7%) eram vacinados contra a hepatite B (receberam 
≥ 3 doses da vacina), 31,6% não eram (receberam zero, uma ou duas 
doses) e 19,6% não sabiam o seu status vacinal. A cobertura vacinal 
para a hepatite B aumentou de 26,0% entre os estudantes do primeiro 
ano para 70,6% entre os estudantes do sexto ano, enquanto a prevalência 
de status vacinal ignorado diminuiu de 39,7% entre os estudantes do 
primeiro ano para 2,4% entre os estudantes do sexto ano. A frequência 
de estudantes não vacinados variou de 23,7% entre os estudantes do 
quinto ano a 34,4% entre os estudantes do primeiro ano. Apenas 34,8% 
dos estudantes vacinados realizaram o teste anti-HBs após a vacinação. 
Entre esses estudantes de medicina encontramos uma baixa adesão à 
vacinação contra a hepatite B e ao teste sorológico pós-vacinal. Um 
amplo programa de imunização contra a hepatite B deveria ser oferecido 
aos estudantes, nessa escola médica.
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